SPOTLIGHT -
The Importance of Access to Care for Multiple Myeloma in Community Settings
For clinicians practicing in the community, constant communication and education from those in institutions may help to produce the best quality of care for patients with multiple myeloma.
CARE Clinic Uses Multidisciplinary Approach For Geriatric Multiple Myeloma
Ashley E. Rosko, MD, specializes in multidisciplinary care for elderly patients with multiple myeloma, and how to make treatment most accessible to them.
Using ‘Intensity’ to Gain ‘Deep Control’ in Myeloma at Ohio State
At first relapse, novel therapies are offered to patients with multiple myeloma at The Ohio State University Comprehensive Cancer Center-The James.
BiTE Therapy May Impact Standard of Care in Multiple Myeloma, Expert Says
Ashley E. Rosko, MD, highlights potential changes on the horizon to the standard of care in multiple myeloma therapy, and discussed the personalization of treatment based on transplant eligibility.
Transplant Eligibility in Patients With NDMM
Naresh Bumma, MD, reviews data from the final analysis of the GRIFFIN trial investigating a quadruplet induction therapy regimen in newly-diagnosed multiple myeloma and discusses how patients are evaluated for transplant.
Treatment Approaches for Patients With Newly-Diagnosed Multiple Myeloma (NDMM)
Ashley Rosko, MD, presents the case of a 57-year-old male with newly-diagnosed multiple myeloma for discussion.
Treating Older Patients With Myeloma: Is Frailty More Important Than Age?
In this peer-to-peer discussion two experts discuss the nuances and challenges of treating elderly patients with myeloma, and why therapies need to be tailored based on frailty status rather than age.
